74 related articles for article (PubMed ID: 4970532)
1. Intracellular distribution of hepatic carbonic anhydrase in mice bearing Ehrlich ascites carcinoma or with spontaneous mammary carcinoma.
Suzuki S; Ogawa E
Gunma J Med Sci; 1967 Mar; 16(1):74-8. PubMed ID: 4970532
[No Abstract] [Full Text] [Related]
2. Hepatic arginase activity in mice bearing Ehrlich ascites carcinoma.
Abreu LA; Abreu RR
Arch Geschwulstforsch; 1968; 31(1):1-4. PubMed ID: 5674790
[No Abstract] [Full Text] [Related]
3. [Studies on liver glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase of Ehrlich ascites tumor-bearing mice (author's transl)].
Asanami S
Shikwa Gakuho; 1979 Feb; 79(2):361-8. PubMed ID: 298052
[No Abstract] [Full Text] [Related]
4. Study on tyrosine: 2-oxoglutarate aminotransferase activity in the liver of tumor-bearing and injured mice.
Oka Y
Nagoya J Med Sci; 1971 Jun; 34(1):1-11. PubMed ID: 5113240
[No Abstract] [Full Text] [Related]
5. Proteolytic activity in liver cells from mouse, rat, Ehrlich ascites carcinoma bearing mouse and in Ehrlich ascites carcinoma cells.
Tekavcic E; Skrk J; Suhar A; Lebez D
Neoplasma; 1976; 23(5):515-22. PubMed ID: 10531
[TBL] [Abstract][Full Text] [Related]
6. Effect of an alkylating agent on liver arginase in normal and Ehrlich carcinoma bearing mice.
Abreu RR; Abreu LA
Hospital (Rio J); 1969 Jul; 76(1):345-51. PubMed ID: 5307536
[No Abstract] [Full Text] [Related]
7. Chronic administration of caffeine: effect on the activities of hepatic antioxidant enzymes of Ehrlich ascites tumor-bearing mice.
Mukhopadhyay S; Mondal A; Poddar MK
Indian J Exp Biol; 2003 Apr; 41(4):283-9. PubMed ID: 15255635
[TBL] [Abstract][Full Text] [Related]
8. Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
Foster JD; Wiedemann JM; Pan CJ; Chou JY; Nordlie RC
Arch Biochem Biophys; 2001 Sep; 393(1):117-22. PubMed ID: 11516168
[TBL] [Abstract][Full Text] [Related]
9. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
Lehmann W; Graetz H; Widmayer R; Langen P
Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of lactate dehydrogenase in Ehrlich Ascites cells & host's liver.
Dohadwala MM; Datta AG; Chaudhuri L
Indian J Biochem Biophys; 1980 Jun; 17(3):191-3. PubMed ID: 7450804
[No Abstract] [Full Text] [Related]
11. [Disorders in metabolism of superoxide radicals in tumor-bearing mice during development of Ehrlich ascites carcinoma and their normalization under the effect of ruboxyl].
Gurevish SM; Vartanian LS; Nagler LG
Vopr Med Khim; 1993; 39(6):16-20. PubMed ID: 8303863
[TBL] [Abstract][Full Text] [Related]
12. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
[TBL] [Abstract][Full Text] [Related]
13. Factors elevating liver tyrosine: 2-oxoglutarate aminotransferase activity in tumor-bearing mice.
Kato Y
Nagoya J Med Sci; 1967 Sep; 30(2):211-23. PubMed ID: 4384080
[No Abstract] [Full Text] [Related]
14. Changes in lipoprotein lipase activity (LPLA) in tumor cells and tissues in mice bearing Ehrlich ascites tumor.
Bálint Z; Holczinger L
Bull Cancer; 1984; 71(5):412-8. PubMed ID: 6525466
[TBL] [Abstract][Full Text] [Related]
15. Thiamine metabolism in the liver of mice with Ehrlich ascites carcinoma.
Trebukhina RV; Ostrovsky YuM ; Shapot VS; Petushok VG; Velichko MG; Tumanov VN; Mikhaltsevich GN
Neoplasma; 1982; 29(3):257-68. PubMed ID: 6127634
[TBL] [Abstract][Full Text] [Related]
16. Studies on liver arginase in mice with Ehrlich carcinoma.
Abreu LA; Abreu RR
Hospital (Rio J); 1968 Apr; 73(4):1287-90. PubMed ID: 5307510
[No Abstract] [Full Text] [Related]
17. Transitions of hepatic purine metabolism of Ehrlich ascites tumor bearing mice in different phases of tumor growth.
Schwendel A; Siems WG; Grune T; Holzhütter HG
Biochem Mol Biol Int; 1994 Oct; 34(3):457-63. PubMed ID: 7833823
[TBL] [Abstract][Full Text] [Related]
18. Subcellular distribution of inorganic pyrophosphatase activity in various normal and neoplastic cell types.
Shatton JB; Williams A; Weinhouse S
Cancer Res; 1983 Aug; 43(8):3742-7. PubMed ID: 6134580
[TBL] [Abstract][Full Text] [Related]
19. Comparison of folylderivative biosynthesis in Ehrlich ascites carcinoma cells and in some organs of healthy and tumor-bearing mice.
Sikora E; Grzelakowska-Sztabert B
Neoplasma; 1984; 31(2):139-48. PubMed ID: 6717683
[TBL] [Abstract][Full Text] [Related]
20. Is ribonucleotide reductase in Ehrlich ascites mammary tumour cells the target of a growth inhibitor purified from bovine mammary gland?
Langen P; Lehmann W; Graetz H; Böhmer FD; Grosse R
Biomed Biochim Acta; 1984; 43(12):1377-83. PubMed ID: 6398699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
